From coins to cancer therapy: Gold, silver and copper complexes targeting human topoisomerases

Area of Science:

• Oncology
• Medicinal Chemistry
• Biochemistry

Background:

• Cancer remains a leading global cause of death despite advances in prevention and therapy.
• Metal-based compounds, inspired by cisplatin, are investigated for novel anticancer drug development.
• Human topoisomerases are critical enzymes for cell function and are often overexpressed in cancer.

Purpose of the Study:

• To review recent findings on gold, silver, and copper complexes as antitumor agents.
• To highlight the impact of these metal complexes on human topoisomerases.
• To identify promising lead compounds for developing new anticancer therapies.

Main Methods:

• Literature review of recent studies on metal-based anticancer agents.
• Analysis of the mechanism of action of gold, silver, and copper complexes.
• Focus on the interaction of these complexes with human topoisomerases.

Main Results:

• Gold, silver, and copper complexes demonstrate potential as antitumor agents.
• These metal complexes influence the activity of human topoisomerases.
• Specific complexes show promise for targeting cancer-related enzymatic pathways.

Conclusions:

• Metal complexes offer a promising avenue for developing safer and more effective cancer treatments.
• Targeting human topoisomerases with novel metal compounds is a viable strategy.
• Further research into lead complexes could yield next-generation anticancer drugs.